{"id":"https://openalex.org/W4361909907","doi":"https://doi.org/10.1158/1078-0432.22454996.v1","title":"Supplementary Figure 2 from Differential Expression of 2\u2032,3\u2032-Cyclic-Nucleotide 3\u2032-Phosphodiesterase and Neural Lineage Markers Correlate with Glioblastoma Xenograft Infiltration and Patient Survival","display_name":"Supplementary Figure 2 from Differential Expression of 2\u2032,3\u2032-Cyclic-Nucleotide 3\u2032-Phosphodiesterase and Neural Lineage Markers Correlate with Glioblastoma Xenograft Infiltration and Patient Survival","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361909907","doi":"https://doi.org/10.1158/1078-0432.22454996.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22454996.v1","doi":"https://doi.org/10.1158/1078-0432.22454996.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22454996.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Differential_Expression_of_2_3_-Cyclic-Nucleotide_3_-Phosphodiesterase_and_Neural_Lineage_Markers_Correlate_with_Glioblastoma_Xenograft_Infiltration_and_Patient_Survival/22454996/1/files/39906113.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Differential_Expression_of_2_3_-Cyclic-Nucleotide_3_-Phosphodiesterase_and_Neural_Lineage_Markers_Correlate_with_Glioblastoma_Xenograft_Infiltration_and_Patient_Survival/22454996/1/files/39906113.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051851997","display_name":"Michael Zorniak","orcid":"https://orcid.org/0000-0002-5428-7989","observed_orcids":["https://orcid.org/0000-0002-5428-7989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Zorniak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017967519","display_name":"Paul A. Clark","orcid":"https://orcid.org/0000-0002-1608-1146","observed_orcids":["https://orcid.org/0000-0002-1608-1146"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul A. Clark","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030891551","display_name":"Heather E. Leeper","orcid":"https://orcid.org/0000-0003-2840-611X","observed_orcids":["https://orcid.org/0000-0003-2840-611X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heather E. Leeper","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021219150","display_name":"Matthew D. Tipping","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew D. Tipping","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"David M. Francis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M. Francis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103118499","display_name":"Kevin Robert Kozak","orcid":"https://orcid.org/0000-0002-2930-5831","observed_orcids":["https://orcid.org/0000-0002-2930-5831"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin R. Kozak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027142293","display_name":"M. Shahriar Salamat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Shahriar Salamat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5054371127","display_name":"John S. Kuo","orcid":"https://orcid.org/0000-0001-6809-4806","observed_orcids":["https://orcid.org/0000-0001-6809-4806"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John S. Kuo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cnpase","display_name":"CNPase","score":0.9380000233650208},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.972000002861023},{"id":"https://openalex.org/keywords/glioma-stem-cells","display_name":"glioma stem cells","score":0.8489999771118164},{"id":"https://openalex.org/keywords/patient-survival","display_name":"patient survival","score":0.9589999914169312},{"id":"https://openalex.org/keywords/immunodeficient-mice","display_name":"immunodeficient mice","score":0.7829999923706055}],"concepts":[{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.6980358362197876},{"id":"https://openalex.org/C2776817793","wikidata":"https://www.wikidata.org/wiki/Q6553369","display_name":"Lineage (genetic)","level":3,"score":0.5723745226860046},{"id":"https://openalex.org/C2780215583","wikidata":"https://www.wikidata.org/wiki/Q946700","display_name":"Cyclic nucleotide phosphodiesterase","level":4,"score":0.562068521976471},{"id":"https://openalex.org/C512185932","wikidata":"https://www.wikidata.org/wiki/Q28745","display_name":"Nucleotide","level":3,"score":0.5422074198722839},{"id":"https://openalex.org/C62826618","wikidata":"https://www.wikidata.org/wiki/Q424304","display_name":"Phosphodiesterase","level":3,"score":0.5301144123077393},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.529042661190033},{"id":"https://openalex.org/C2780801072","wikidata":"https://www.wikidata.org/wiki/Q837512","display_name":"Differential diagnosis","level":2,"score":0.46662959456443787},{"id":"https://openalex.org/C153400128","wikidata":"https://www.wikidata.org/wiki/Q3150731","display_name":"Infiltration (HVAC)","level":2,"score":0.44583746790885925},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4373297095298767},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37362921237945557},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3580915033817291},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35541781783103943},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2734893262386322},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.25630611181259155},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.22209057211875916},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13801789283752441},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.12707611918449402},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.10049337148666382},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22454996.v1","doi":"https://doi.org/10.1158/1078-0432.22454996.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22454996.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Differential_Expression_of_2_3_-Cyclic-Nucleotide_3_-Phosphodiesterase_and_Neural_Lineage_Markers_Correlate_with_Glioblastoma_Xenograft_Infiltration_and_Patient_Survival/22454996/1/files/39906113.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22454996","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Differential_Expression_of_2_3_-Cyclic-Nucleotide_3_-Phosphodiesterase_and_Neural_Lineage_Markers_Correlate_with_Glioblastoma_Xenograft_Infiltration_and_Patient_Survival/22454996","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22454996.v1","doi":"https://doi.org/10.1158/1078-0432.22454996.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22454996.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Differential_Expression_of_2_3_-Cyclic-Nucleotide_3_-Phosphodiesterase_and_Neural_Lineage_Markers_Correlate_with_Glioblastoma_Xenograft_Infiltration_and_Patient_Survival/22454996/1/files/39906113.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4361909907.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2142815489","https://openalex.org/W4361944679","https://openalex.org/W4361909843","https://openalex.org/W2035440069","https://openalex.org/W7098273986","https://openalex.org/W4298839404","https://openalex.org/W2784767526","https://openalex.org/W2322827398","https://openalex.org/W2588230331","https://openalex.org/W6939552702"],"abstract_inverted_index":{"PDF":[0],"file,":[1],"80KB,":[2],"Differential":[3],"neural":[4],"lineage":[5],"marker":[6],"expression":[7],"associate":[8],"with":[9],"survivability":[10],"of":[11],"GSC-induced":[12],"xenografts":[13],"in":[14],"immunodeficient":[15],"mice.":[16]},"counts_by_year":[],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2023-04-05T00:00:00"}